Earnings Winners & Losers: MMSI, STMN, WMGI, RWLK, EXAS
As the earnings season continues, Medtech Insight takes a look at dental firm Straumann’s performance, as well as that of some mid- to small-cap companies – including extremities implant specialist Wright Medical – highlighting which we believe to be the season’s winners and losers.
You may also be interested in...
Among the medtech companies who have released their first-quarter 2017 sales and earnings, Johnson & Johnson and Merit Medical Systems reported progress in their long-term plans to reshape their medical device businesses, while Abbott and Zimmer Biomet received some bad news in the quarter. Smith & Nephew shows signs of a turnaround, and perennial "winner" Edwards Lifesciences provided updates on some important developments in their flagship transcatheter valve business.
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.
The system has the potential to be the first FDA-cleared device for harvesting intact cancer cells from a blood sample for subsequent analysis.